Update your location to show providers, locations, and services closest to you.
Endocrinologist (Diabetes & Hormones Specialist)
Dr. Kenneth Cusi is a Professor of Medicine at the Division of Endocrinology, Diabetes & Metabolism in the Department of Medicine at the University of Florida. He received his medical degree in Argentina from the University of Buenos Aires School of Medicine and is board certified in both Internal Medicine and Endocrinology, Diabetes & Metabolism. He completed his residency at the Center of Medical Education & Clinical Research (CEMIC) in Buenos Aires, Argentina, and a clinical fellowship at Baylor College of Medicine in Houston. Prior to joining the University of Florida, Dr. Cusi was a faculty for over 15 years at the Diabetes Division, University of Texas Health Science Center at San Antonio (UTHSCSA) and the Veterans Health Administration System in Texas; one of the leading diabetes programs in the country. He is a fellow of the American College of Physicians (ACP) and the American Association of Clinical Endocrinologists (AACE). He has actively participated in many clinical diabetes programs and in the training of many young researchers and clinicians. He is the principal investigator in ongoing NIH grants, investigator-initiated as well as multicenter industry-sponsored studies, with a focus on obesity, type 2 diabetes mellitus and nonalcoholic fatty liver disease (NAFLD).
This study is open to adults who are at least 18 years old and have a body mass index of 27 kg/m² or more. People can take part if they have type 2 diabetes and if they are currently being treated only with diet and exercise or with specific…
This study is open to adults who are at least 18 years old and have a body mass index (BMI) of 30 kg/m² or more, or a BMI of 27 kg/m² or more and at least one health problem related to their weight. People with type 2 diabetes cannot take part…
To determine the safety and efficacy of low-dose pioglitazone (15 mg per day) on liver histology in in patients with T2DM with biopsy-proven nonalcoholic steatohepatitis (NASH).
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
— Dr. Kenneth CusiPatients should expect to interact with a physician with clinical experience that will listen to them, offer a comprehensive diagnostic and management plan agreed upon with the patient in shared-decision making, and supportive during follow-up. To foster the physician-patient relationship and positive outcomes, the patient is also expected to be proactive in keeping up with appointments and the plan established.
December 21, 2020
It’s a potential killer. And many of the people who are most susceptible to the disease don’t even know it exists. Physicians remain uncertain of its…
College of Medicine, +2 more
November 20, 2020
Pushed by the obesity epidemic, a rising number of Americans are being diagnosed with nonalcoholic fatty liver disease, a condition that can lead to liver…
College of Medicine, Diabetes Institute, +2 more
